Jiadong Zhou

Jiadong Zhou

Auto-generated profile, based on publicly available information

Jiadong Zhou

Department of Anatomy, Histology and Embryology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 October 2020 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
XZXiao Albert Zhou
Xiao Albert Zhou
JZJiadong Zhou
Jiadong Zhou
Long ZhaoLong Zhao
Long Zhao
GYGuihui Yu
Guihui Yu
JZJun Zhan
Jun Zhan
JWJiadong Wang
Jiadong Wang
Significance: Aberrant PD-1 expression is known to inhibit T cell effector activity and plays a pivotal role in tumor immune escape. Since maintaining an appropriate level of PD-1 expression is of great significance, it should be highly regulated at multiple levels. Despite extensive studies to date on this topic, it remains unclear how PD-1 expression is precisely regulated at the posttranslation level both during T cell activation and among the tumor microenvironment. Here, we show that KLHL22 maintains PD-1 protein homeostasis by degrading incompletely glycosylated PD-1, thereby preventing excessive T cell suppression. KLHL22-mediated degradation of PD-1 protein will be ineffective in response to either the tumor microenvironment or treatment with 5-FU, resulting in excessive PD-1 accumulation and reduced T cell activity.